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Abstract The mesopontine rostromedial tegmental
nucleus (RMTg) is a GABAergic structure in the ventral
midbrain and rostral pons that, when activated, inhibits
dopaminergic neurons in the ventral tegmental area and
substantia nigra compacta. Additional strong outputs from
the RMTg to the pedunculopontine tegmental nucleus pars
dissipata, dorsal raphe nucleus, and the pontomedullary
gigantocellular reticular formation were identiﬁed by
anterograde tracing. RMTg neurons projecting to the ven-
tral tegmental area express the immediate early gene Fos
upon psychostimulant administration. The present study
was undertaken to determine if neurons in the RMTg that
project to the additional structures listed above also express
Fos upon psychostimulant administration and, if so, whe-
ther single neurons in the RMTg project to more than one
of these structures. We found that about 50% of RMTg
neurons exhibiting retrograde labeling after injections of
retrograde tracer in the dorsal raphe or pars dissipata of the
pedunculopontine tegmental nucleus express Fos after
acute methamphetamine exposure. Also, we observed that
a signiﬁcant number of RMTg neurons project both to the
ventral tegmental area and one of these structures. In
contrast, methamphetamine-elicited Fos expression was
not observed in RMTg neurons labeled with retrograde
tracer following injections into the pontomedullary retic-
ular formation. The ﬁndings suggest that the RMTg is an
integrative modulator of multiple rostrally projecting
structures.
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Introduction
The ventral tegmental area (VTA) gives rise to the meso-
corticolimbic dopaminergic system (Dahlstrom and Fuxe
1964) and is the substrate for the initiation of behavioral
sensitization to psychostimulants (Kalivas and Webber
1988; Kalivas and Stewart 1991; Hooks et al. 1992;
Perugini and Vezina 1994; Cador et al. 1995, 1999; Bjijou
et al. 1996; Vezina 1996; Vanderschuren and Kalivas
2000). Dopamine (DA) neurons in the VTA respond with
increases or decreases in their ﬁring rates to novelty,
reward, aversive stimuli, cues predicting rewards or aver-
sive stimuli, and omissions of expected rewards or aversive
stimuli (Schultz 1998, 2007; Bromberg-Martin et al. 2010).
Understanding of the mechanisms by which the activity of
DA neurons is linked to circumstances, however, remains
incomplete. The lateral habenula (LHb), which increases
ﬁring in response to aversive stimuli and reward omission
(Christoph et al. 1986; Gao et al. 1996; Ji and Shepard
2007; Matsumoto and Hikosaka 2007; Shumake et al.
2010; Hong et al. 2011), could conceivably inhibit dopa-
mine neurons in turn, due to its direct projections to the
VTA (Herkenhan and Nauta 1979; Araki et al. 1988;
Omelchenko et al. 2009). However, LHb projections to the
ventral tegmental area are mainly glutamatergic (Geisler
et al. 2007; Brinschwitz et al. 2010), thus suggesting that
LHb inhibition of DA neurons is mediated indirectly,
possibly by a relay in another structure.
Evidence that such a mediator region exists was pro-
vided by Chou et al. (2004), who showed that a cluster of
cells in the paramedian tegmentum behind the VTA pro-
jects to the VTA and inﬂuences fear-elicited behaviors.
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Chou in Chou et al. 2004) showed that these neurons are
activated by aversive stimuli. In deﬁnitive papers, Jhou and
colleagues (Jhou et al. 2009a, b) showed that this structure
is GABAergic, receives dense projections from the LHb,
and projects strongly to the VTA and substantia nigra
compacta (SNC). Earlier, Scammell et al. (2000) had
identiﬁed in rats a cluster of neurons that express Fos after
administration of modaﬁnil, and designated it as the ‘‘ret-
roVTA’’. Later, Perrotti et al. (2005) showed a similar
cluster that expressed deltaFosB, a long-lived splice variant
of FosB, after the chronic administration of amphetamine
and called it the ‘‘posterior tail of the VTA’’. Geisler et al.
(2008) demonstrated what appears to be the same cluster of
Table 1 Numbers of
retrogradely labeled and double-
labeled neurons following
brainstem tracer injections
All entries reﬂect data from the
RMTg and region just
surrounding it (see ‘‘Materials
and methods’’) from 3 sections/
case
a Paired samples t test
Injection site Retrogradely labeled neurons Double-labeled neurons Percent double-labeled neurons
Case RMTg Outside RMTg Outside RMTg Outside
VTA
10192 152 118 74 17 48% 14%
11077 150 60 75 17 50% 28%
11080 59 18 32 1 54% 5%
11083 115 115 46 7 40% 6%
12051 176 131 198 28 47% 14%
Mean ± SE 130 ± 35 88 ± 21 85 ± 29 14 ± 44 8 ± 21 3 ± 4
p = 0.001
a
PPTg
10193 84 101 33 10 40% 9%
10202 104 80 80 18 77% 30%
10203 84 20 35 6 42% 22%
11058 77 52 50 14 65% 26%
11059 72 72 46 18 64% 25%
12050 117 107 59 8 50% 7%
Mean ± SE 89 ± 77 2 ± 13 50 ± 71 2 ± 25 4 ± 61 9 ± 4
p = 0.001
DR
10200 63 80 22 4 35% 5%
11060 91 140 44 32 48% 22%
11061 44 98 30 2 68% 2%
11119 66 92 34 3 51% 4%
12053 50 65 23 7 46% 11%
Mean ± SE 71 ± 11 97 ± 10 35 ± 59 ± 44 7 ± 59 ± 4
p = 0.005
RtGi
11180 37 83 5 9 14% 11%
11184 23 14 2 2 8% 14%
11191 25 131 1 21 4% 16%
11192 38 129 8 27 21% 21%
11214 17 43 1 4 6% 9%
11215 32 72 2 6 6% 8%
11216 49 76 2 11 4% 14%
11217 27 73 2 15 7% 20%
11223 26 125 5 23 19% 18%
11224 40 99 3 15 7% 15%
11225 33 89 1 18 3% 20%
Mean ± SE 31 ± 38 5 ± 10 3 ± 0.5 13 ± 28 ± 21 5 ± 1
p = 0.008
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123Fos-expressing neurons after cocaine self-administration,
and showed that the neurons comprising it project to the
VTA. Upon further investigation, Jhou et al. (2009b) and
Kauﬂing et al. (2009, 2010a) concluded that all these
workers were studying the same structure, which Jhou et al.
(2009b) named the mesopontine rostromedial tegmental
nucleus (RMTg). This GABAergic midbrain structure has
now been shown to mediate the LHb inﬂuence on the VTA
(Hong et al. 2011): glutamatergic LHb neurons project to
GABAergic neurons of the RMTg, which in turn exert an
inhibitory inﬂuence on dopaminergic VTA/SNC neurons.
Jhou et al. (2009b) utilized the anterogradely transported
tracer, PHA-L, to characterize the efferent projections of
the RMTg, and showed particularly robust projections to
the pedunculopontine tegmental nucleus pars dissipata
(PPTg), dorsal raphe nucleus (DR), and pontomedullary
paramedian gigantocellular reticular formation (RtGi),
indicating that important inﬂuences of the RMTg are not
necessarily limited to the VTA.
At present, the criteria available to designate a neuron as
belonging to the RMTg include input from the LHb, pro-
jection to the VTA/SNC, GABAergic phenotype, and the
expression of Fos following some aversive stimuli (Jhou
et al. 2009a), but invariably after administration of any
psychostimulant drug (Kauﬂing et al. 2010b). The present
study was undertaken to determine if neurons in the RMTg
that project to the PPTg, DR, and RtGi also express Fos
upon psychostimulant administration. At least for the DR
and PPTg, this was found to be the case, which led us to
examine if single neurons in the RMTg might project to
more than one of these structures. We herein show that
single neurons of the RMTg do indeed project to multiple
targets, suggesting that RMTg neurons may be involved in
modulating activity coordinately in several structures,
including the PPTg, DR, and VTA.
Materials and methods
Male Sprague–Dawley rats (Harlan, Indianapolis, IN,
USA) weighing 225–250 g were used in accordance with
the guidelines mandated in the National Institutes of Health
Guide for the Care and Use of Laboratory Animals. The
rats were housed on a 12-h light–dark cycle in groups of
two to four until surgeries were performed, after which all
were singly housed. Access to food and water was provided
ad libitum. Unless otherwise stated, chemicals were pur-
chased from Sigma (St. Louis, MO, USA).
Table 2 Numbers of
retrogradely labeled and double-
labeled neurons for tracer
(FG and CTb) injection
combinations
All entries reﬂect data from the
RMTg and region just
surrounding it (see ‘‘Materials
and methods’’) from 3 sections/
case
a Injection 1, injection 2
b Paired samples t test
Injection combination Retrogradely
labeled neurons
Double-labeled
neurons
Percent double-
labeled neurons
Case RMTg Surround RMTg Surround RMTg Surround
PPTg–VTA
11082 230 (108, 122)
a 127 (64, 63) 28 2 12% 2%
11083 272 (129, 143) 162 (67, 95) 35 6 13% 3%
11090 164 (71, 93) 108 (65, 43) 8 0 5% 0%
12051 146 (57, 89) 112 (62, 50) 9 1 6% 1%
Mean ± SE 203 ± 29 127 ± 12 20 ± 12 2 ± 19 ± 21 ± 0.5
p = 0.01
b
DR–VTA
11118 226 (115, 111) 207 (92, 115) 18 3 8% 1%
11119 188 (74, 114) 145 (68, 77) 20 6 10% 4%
11121 191 (78, 113) 147 (65, 82) 23 4 12% 3%
12052 203 (81, 122) 123 (44, 79) 18 4 9% 3%
Mean ± SE 202 ± 8 155 ± 18 20 ± 14 ± 0.5 10 ± 12 ± 0.5
p = 0.02
PPTg–DR
11260 98 (60, 38) 65 (33, 32) 6 0 6% 0%
11261 102 (42, 60) 36 (19, 17) 9 0 9% 0%
11264 124 (53, 71) 172 (74, 98) 4 3 3% 2%
11265 65 (49, 16) 46 (25, 21) 3 0 5% 0%
12055 70 (29, 41) 54 (20, 34) 3 1 4% 2%
Mean ± SE 91 ± 10 74 ± 24 5 ± 1 0.8 ± 0.5 5 ± 1 0.5 ± 0.5
p = 0.02
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123Tracer injections
The rats were deeply anesthetized by intraperitoneal
injections of a mixture of ketamine (72 mg/kg) and xyla-
zine (11.2 mg/kg). The anesthetic was injected as a cock-
tail consisting of 45% ketamine (100 mg/ml), 35%
xylazine (20 mg/ml), and 20% saline at a dose of 0.16 ml/
100 g of body weight. The anesthetized rats were placed
into a Kopf stereotaxic instrument and an incision was
made to expose the scull, in which a small burr hole was
made over the injection site. The retrograde tracers, cholera
toxin b subunit (CTb; List Biological Laboratories,
Campbell, CA; 1% in ddH2O) or Fluoro-Gold (FG; Fluo-
rochrome Inc., Englewood, CO; 1% in 0.1 M cacodylate
buffer, pH 7.4) were injected into targeted brain structures
(VTA, DR, PPTg or RtGi) using 1.0 mm ﬁlament-con-
taining borosilicate glass pipettes pulled to tip diameters of
15–20 lm. The tracer solution was injected ionotophoret-
ically using positive current pulses (7 s on and 7 s off for
15 min) of 1 lA (for FG) and 3 lA (for CTb). In order to
generate more retrograde labeling in the vicinity of the
RMTg, some injections of CTb into RtGi were done with
glass pipettes pulled to tip diameters of 30–40 lm from
which the tracer was expelled by air pressure, resulting in
an injected volume of approximately 0.1 ll. The incisions
were closed with wound clips, and the rats were kept warm
until they awakened.
Fixation of brains
Three days following tracer injections, the rats were
given an intraperitoneal injection of methamphetamine
(10 mg/kg). Two hours following methamphetamine
injections, the rats were deeply anesthetized as described
and perfused transaortically with 0.01 M Sorensen’s
phosphate buffer (SPB; pH 7.4) containing 0.9% sodium
chloride and 2.5% sucrose, followed by 0.1 M SPB (pH
7.4) containing 4% paraformaldehyde and 2.5% sucrose.
The perfused brains were removed and placed in the
same ﬁxative for 4 h and then in a 30% sucrose solution
overnight. Five adjacent series of 50 lm sections were
collected, each representing an entire brain from the
Fig. 1 Fos-expressing retrogradely labeled neurons in the RMTg
following injection of CTb in the VTA. a CTb injection site in the
VTA. b Immunoperoxidase detection of retrogradely labeled neurons
(brown, yellow arrows) and Fos expression (black, white arrows)i n
the RMTg. c–e Immunoﬂuorescence images of RMTg neurons
showing Fos immunoreactivity (c, magenta), retrograde labeling (d,
green), and a merged image (e). White arrows in c–e indicate double-
labeled neurons. The round hole in the section at the left edge of the
micrograph is a tissue punch marking the right hemisphere. IPN
interpeduncular nucleus. Scale bars 400 lmi na; 100 lmi nb and c
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123frontal pole to the caudal medulla at sampled intervals of
250 lm. Each series of sections was stored in a separate
glass vial at -20C in cryoprotectant consisting of
0.01 M SPB containing 30% sucrose and 30% ethylene
glycol.
Immunohistochemistry
Some series of sections from each case were processed for
immunoperoxidase and others for immunoﬂuorescence
histochemistry. Sections processed for immunoperoxidase
histochemistry, which produces permanent, non-fading
preparations, were used for the evaluation of injection sites,
efﬁcacy of retrograde transport of the tracer and general
distribution of retrograde labeling relative to the Fos-
expressing RMTg. However, double-immunoperoxidase
preparations show double labeling unreliably. Accordingly,
additional sections processed for immunoﬂuorescence
histochemistry were used to reliably demonstrate and
quantify double labeling.
Immunoperoxidase histochemistry
For immunoperoxidase processing, one series from each
case was immersed in 0.1 M SPB containing 0.1% Triton
X-100 (SPB-t) and anti-Fos antibody (Calbiochem, San
Diego, CA, USA, catalog no. PC38) made in rabbit at a
dilution of 1:3,000. The following day, the sections were
rinsed in 0.1 M SPB-t and immersed for 1 h in 0.1 M SPB-
t containing biotinylated antibody made in donkey against
rabbit IgGs at a dilution of 1:200 (Jackson Immuno-
Research Laboratories Inc., West Grove, PA, USA, catalog
no. 711-065-152). Afterward, the sections were rinsed in
0.1 M SPB-t and then immersed for 1 h in 0.1 M SPB
containing avidin–biotin-peroxidase complex (ABC) at a
dilution of 1:200 (Vector Laboratories, Burlingame, CA,
USA). After rinsing in 0.1 M SPB, the sections were
reacted in 0.025 M Tris buffer (pH 8.0) containing 0.015%
3,30-diaminobenzidine (DAB), 0.4% nickel ammonium
sulfate, and 0.003% hydrogen peroxide (NiDAB), which
generates an insoluble black reaction product. The sections
Fig. 2 Fos-expressing retrogradely labeled neurons in the RMTg
following injection of CTb in the PPTg. a CTb injection site in the
PPTg. b Adjacent section processed for Nos immunoreactivity (black)
veriﬁes that the injection is in the PPTg, pars dissipata. c Retrogradely
labeled neurons (yellow arrows) and Fos expression (white arrows)i n
the RMTg. d–f Immunoﬂuorescence images of RMTg neurons
showing Fos immunoreactivity (d, magenta), retrogradely labeled
neurons (e, green), and a merged image (f). White arrows indicate
double labeling (d–f). PPTg c pedunculopontine tegmental nucleus,
pars compacta; PPTg d pedunculopontine tegmental nucleus, pars
dissipata; IPN interpeduncular nucleus. Scale bars 400 lmi na and b;
100 lmi nc and d
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123were then rinsed in 0.1 M SPB and immersed overnight in
0.1 M SPB containing polyclonal antibodies against CTb
(anti-CTb, List Biological Laboratories, Cambell, CA,
USA, catalog no. 7032A5) made in goat and used at a
dilution of 1:4,000. The following day, after rinsing in
0.1 M SPB, the sections were immersed for 1 h in 0.1 M
SPB containing biotinylated antibody made in donkey
against goat IgGs at a dilution of 1:200 (Jackson, catalog
no. 705-065-003). Afterward, the sections were rinsed in
0.1 M SPB and then immersed for 1 h in 0.1 M SPB
containing ABC at a dilution of 1:200 (Vector). After
rinsing in 0.1 M SPB, the sections were reacted in 0.1 M
SPB containing 0.05% 3,30-diaminobenzidine and 0.003%
hydrogen peroxide (DAB), which generates an insoluble
brown reaction product. In this variation of the immunoper-
oxidase protocol and those to follow, the sections were
then mounted onto gelatin-coated slides and coverslipped
with Permount (Fisher, Pittsburgh, PA, USA).
For immunoperoxidase in cases involving injection of
FG into one brain area and CTb into a different site, one
series from each case was immersed overnight in 0.1 M
SPB-t containing anti-FG (Chemicon International,
Temecula, CA, USA, catalog no. AB153), made in rabbit at
a dilution of 1:3,000. The following day, the sections were
rinsed in 0.1 M SPB-t and immersed for 1 h in 0.1 M SPB
containing biotinylated antibody made in donkey against
rabbit IgGs at a dilution of 1:200 (Jackson). Afterward, the
sections were rinsed in 0.1 M SPB-t and then immersed for
1 h in 0.1 M SPB containing ABC at a dilution of 1:200
(Vector). After rinsing in 0.1 M SPB, the sections were
reacted in NiDAB. The sections were then rinsed in SPB
and immersed overnight in SPB containing polyclonal
Fig. 3 Representative plots at
rostral (a, d) and caudal (b, e)
levels of the RMTg (small black
circles) from cases that received
injections of tracer in the VTA
(a–c) and PPTg (d–f) and were
processed to exhibit
retrogradely labeled neurons
and Fos expression. Brains were
injected on the sides indicated
by the asterisks. Large blue
circles indicate the regions
bordering the RMTg. c and
f Show enlargements of the
caudal levels. Black triangles
Fos expressing neurons,
blue dots retrogradely
labeled neurons, red circles
double-labeled neurons
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123anti-CTb used at a dilution of 1:4,000. The following day,
after rinsing in 0.1 M SPB, the sections were immersed for
1 h in 0.1 M SPB containing biotinylated antibody made in
donkey against goat IgGs at a dilution of 1:200 (Jackson).
Afterward, the sections were rinsed in 0.1 M SPB and then
immersed for 1 h in 0.1 M SPB containing ABC at a dilu-
tion of 1:200 (Vector). After more rinsing in 0.1 M SPB, the
sections were reacted in NiDAB, as described above.
For injections into the DR, one series of each case was
immersed overnight in 0.1 M SPB-t containing anti-5-
hydroxytryptophan (5-HT, Immunostar, Hudson, WI, USA,
catalog no. 2446), made in rabbit at a dilution of 1:1,000.
For injections into the PPTg, one series from each case was
immersed overnight in 0.1 M SPB-t containing anti-nitric
oxide synthase (Nos, Sigma, catalog no. 6715) made in
rabbit at a dilution of 1:3,000. The following day, the
sections that had been immersed in either anti-5-HT or
anti-Nos were further processed similarly. They were
rinsed in 0.1 M SPB-t and immersed for 1 h in 0.1 M SPB
containing biotinylated antibody made in donkey against
rabbit IgGs at a dilution of 1:200 (Jackson). Afterward, the
sections were rinsed in 0.1 M SPB-t and then immersed for
1 h in 0.1 M SPB containing ABC at a dilution of 1:200
(Vector). After more rinsing in 0.1 M SPB, the sections
were reacted in NiDAB.
Fluorescence immunohistochemistry
For immunoﬂuorescence processing, one series from each
case was immersed overnight in 0.1 M SPB-t and poly-
clonal anti-CTb used at a dilution of 1:4,000. The fol-
lowing day, the sections were rinsed in 0.1 M SPB-t and
immersed for 1 h in 0.1 M SPB-t containing DyLight 488
conjugated to anti-sheep IGg made in donkey (Jackson,
catalog no. 713-485-14), which recognizes the anti-CTb
made in goat, used at a concentration of 1:200. The sec-
tions then were rinsed in 0.1 M SPB and immersed over-
night in 0.1 M SPB containing anti-Fos at a concentration
of 1:3,000. The following day, the sections were rinsed in
0.1 M SPB and immersed for 1 h in 0.1 M SPB containing
DyLight 594 conjugated to anti-rabbit IGg made in donkey
(Jackson, catalog no. 711-515-152) used at 1:200. The
sections were rinsed in 0.1 M SPB and mounted and cov-
erslipped with ProLong Gold antifade reagent (Invitrogen).
Fig. 4 Fos-expressing retrogradely labeled neurons in the RMTg
following injection of CTb in the DR. a CTb injection site in the DR.
b Adjacent section processed for 5-HT immunoreactivity (black)
veriﬁes that the injection is in the DR. c Retrogradely labeled neurons
(yellow arrows) and Fos expression (white arrows) in the RMTg.
d–f Immunoﬂuorescence images of RMTg neurons showing Fos
immunoreactivity (d, magenta), retrogradely labeled neurons (e,
green), and a merged image (f). White arrows indicate double
labeling (d–f). IPN interpeduncular nucleus. Scale bars: 400 lmi n
a and b; 100 lmi nc and d
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123For immunoﬂuorescence in cases involving injection of
FG into one brain site and CTb into another, one series from
each case was ﬁrst rinsed in 0.1 M SPB-t and immersed
overnight in 0.1 M SPB-t containing anti-CTb at a con-
centration of 1:4,000. The following day, the sections were
rinsed in 0.1 M SPB-t and immersed for 1 h in 0.1 M SPB-t
containing DyLight 488-anti-sheep IGg conjugate (Jack-
son) at a concentration of 1:200. The sections were rinsed in
0.1 M SPB and immersed overnight in 0.1 M SPB con-
taining anti-FG at a concentration of 1:5,000. The following
day, the sections were rinsed in 0.1 M SPB and immersed
for 1 h in 0.1 M SPB containing DyLight 594-anti-rabbit
conjugate (Jackson) at a concentration of 1:200. The sec-
tions were rinsed in 0.1 M SPB and mounted onto gelatin-
coated slides and coverslipped with ProLong Gold.
Analysis of labeling
SectionswereviewedwithanOlympusBX51microscopein
the brightﬁeld or immunoﬂuorescence modes, and digital
micrographs were generated using a DVC 2000C-00-GE-
MBFdigitalcamera.Neuronswereplottedwiththeaidofthe
Neurolucidahardware–softwareplatform(MBFBioscience,
Williston, VT, USA, version 5.65) such that retrogradely
labeledneurons,Fos-containingneuronsanddouble-labeled
neurons were designated with distinct markers. These plots
were exported into Adobe Illustrator CS2 to generate maps
showing three sections of the RMTg spaced at 250 lm for
each case. Quantiﬁcation of the markers for Fos, retrograde
labeling and double labeling was performed with the aid of
the Neurolucida NeuroExplorer program (MBF Bioscience,
version 4.70.3). Counts were generated uniformly across all
cases by delineating the RMTg with a circle of arbitrarily
designated area (0.32 mm
2) surrounding the spot of densest
Fos labeling. The region just surrounding the RMTg, was
designatedbyalarger(1.15 mm
2)circlefromwhichthearea
of the smaller circle was subtracted, leaving 0.83 mm
2. The
numbers of double-labeled neurons, i.e. Fos-expressing ret-
rogradely labeled neurons within these two arbitrarily des-
ignated regions were expressed as percentages of total
retrogradelylabeledneuronstherein.Inordertodetermineif
enrichments of double labeling were present in the RMTg,
the mean percentages of double-labeled neurons within the
RMTg circle were compared with those in the arbitrarily
Fig. 5 Fos-expressing retrogradely labeled neurons in the RMTg
following injection of CTb in the RtGi. a CTb pressure injection site
(see ‘‘Materials and methods’’ section) in the RtGi. b Immunoperox-
idase detection of uncharacteristically numerous retrogradely labeled
neurons (yellow arrows) and Fos expression (white arrows) in the
RMTg. c–e Immunoﬂuorescence images of RMTg neurons showing
Fos immunoreactivity (c, magenta), retrograde labeling (d, green),
and a merged image (e), conﬁrming the absence of double labeling.
IPN interpeduncular nucleus. Scale bars 400 lmi na; 100 lmi n
b and c
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123deﬁned area just outside of the RMTg using a paired t test
with a 95% conﬁdence interval. For each injection site or
combination of injection sites, 4–11 cases were used
(Tables 1, 2). Statistics were done with the aid of SPSS
software.
Results
Single CTb injections
VTA
Consistent with a published report in which the retrograde
tracer Fluoro-Gold was used (Jhou et al. 2009b), injections
of CTb into the VTA exhibited double labeling with Fos
immunoreactivity in 48 ± 2% of retrogradely labeled
neurons (n = 5) within the cluster of Fos-immunoreactive
neurons designated as the RMTg, as compared to 13 ± 4%
double labeling of retrogradely labeled neurons in the area
immediately surrounding the RMTg (Figs. 1, 3a–c, 7). A
representative plot of the results for one VTA case is shown
in Fig. 3, which illustrates rostral (Fig. 3a) and more caudal
(Fig. 3b) levels of the RMTg. The maps in Fig. 3 and
similar maps to follow (i.e., Figs. 6, 11) show localization
of the retrograde tracer, Fos expression, and, if present,
double-labeled neurons. In contrast, in cases in which no
methamphetamine was administered, there were few Fos-
immunoreactive neurons (data not shown), and in cases in
which the injection sites were misplaced, there was no
Fig. 6 Representative plots at
rostral (a, d) and caudal (b, e)
levels of the RMTg (small black
circles) from cases that received
injections of tracer in the DR
(a–c) and RtGi (d–f) and were
processed to exhibit
retrogradely labeled neurons
and Fos expression. Brains were
injected on the sides indicated
by the asterisks. Large blue
circles indicate the regions
bordering the RMTg. c and
f Show enlargements of the
caudal levels. Black triangles
Fos expressing neurons,
blue dots retrogradely
labeled neurons, red circles
double-labeled neurons
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123Fig. 7 Graph showing the
percentages of double-labeled
neurons in the RMTg compared
to the region surrounding it for
four different injection sites:
PPTg (n = 6), DR (n = 5),
VTA (n = 5), and RtGi
(n = 11). *p\0.01 (paired
t test)
Fig. 8 Retrogradely labeled neurons in the RMTg following injec-
tions of CTb in the PPTg and FG in the VTA. a CTb injection site in
the PPTg. b Adjacent section processed for Nos immunoreactivity
(black) veriﬁes that the injection shown in ‘a’ is in the PPTg, pars
dissipata. c FG injection site in the VTA. d CTb-labeled neurons
(yellow arrows) and FG-labeled neurons (white arrows) in the RMTg.
e–g Immunoﬂuorescence images of RMTg neurons showing FG-
labeled RMTg neurons (e, magenta), CTb-labeled RMTg neurons
(f, green), and a merged image (g). White arrows indicate double
labeling (e–g). PPTg c pedunculopontine tegmental nucleus, pars
compacta; PPTg d pedunculopontine tegmental nucleus, pars dissi-
pata; IPN interpeduncular nucleus. Scale bars 400 lmi na–c; 100 lm
in d and e
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123enrichment of retrogradely labeled or double-labeled neu-
rons in the RMTg as compared to the surrounding region.
PPTg
Following injections of CTb into the pars dissipata of the
PPTg, 56 ± 6% of the retrogradely labeled neurons (n = 6)
within the RMTg exhibited Fos-immunoreactivity com-
pared to 19 ± 4% in the area immediately surrounding the
RMTg (Figs. 2, 3d–f, 7). The locations of injection sites
(Fig. 2a) within the PPTg dissipata were veriﬁed by dem-
onstrating Nos expression (Fig. 2b), which co-localizes in
cholinergic neurons that characterize the PPTg region
(Armstrong et al. 1983). A representative plot of the results
for one PPTg case is shown in Fig. 3, which illustrates
rostral (Fig. 3d) and caudal (Fig. 3f) levels of the RMTg.
DR
47 ± 5% of retrogradely labeled neurons (n = 5) in the
RMTg were double labeled following injections of CTb
in the DR compared to 9 ± 4% in the area immediately
surrounding the RMTg (Figs. 4, 6a–c, 7). DR injection
sites (Fig. 4a) were veriﬁed by demonstrating 5-HT
immunoreactivity in adjacent sections (Fig. 4b), which
identiﬁed serotoninergic neurons that characterize that
structure (Aghajanian et al. 1967).
RtGi
In contrast, injections of CTb into the RtGi region (Fig. 5)
resulted in few retrogradely labeled neurons in the RMTg
(n = 11), of which 8 ± 2% were double labeled. Greater
numbers of retrogradely labeled neurons were present in
the area surrounding the RMTg following injections in the
RtGi and the percentage of these that were double labeled
(15 ± 1%) was comparable to that observed within the
RMTg (Figs. 5, 6d–f, 7). A representative plot of the
results from one RtGi injection is shown in Fig. 6, which
illustrates rostral (Fig. 6d) and caudal (Fig. 6e) RMTg
levels.
Fig. 9 Retrogradely labeled neurons in the RMTg following injec-
tions of CTb in the DR and FG in the VTA. a CTb injection site in the
DR. b Adjacent section processed for 5-HT immunoreactivity (black)
veriﬁes that the injection shown in a is in the DR. c FG injection site
in the VTA. d CTb-labeled neurons (yellow arrows), FG-labeled
neurons (white arrows) in the RMTg. e–g Immunoﬂuorescence
images of RMTg neurons showing FG-labeled RMTg neurons
(e, magenta), CTb-labeled RMTg neurons (f, green), and a merged
image (g). White arrows indicate double labeling (e–g). IPN
interpeduncular nucleus. Scale bars 400 lmi na–c; 100 lmi n
d and e
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In a series of cases in which FG was injected into the VTA
and CTb into the PPTg, 9 ± 2% of retrogradely labeled
neurons within the RMTg (n = 4) exhibited both tracers,
indicating RMTg neurons that project to both the VTA and
PPTg, compared to 1 ± 0.5% in the area immediately
surrounding the RMTg (Fig. 8). Similarly, injections of FG
into the VTA and CTb into the DR produced 10 ± 1% of
retrogradely labeled neurons (n = 4) within the RMTg
exhibiting both markers compared to 2 ± 0.5% in the area
immediately surrounding the RMTg (Fig. 9). Injections
of FG into PPTg and CTb into DR produced 5 ± 1% of
retrogradely labeled neurons (n = 5) within the RMTg
exhibiting both markers compared to 0.5 ± 0.5% in the
area immediately surrounding the RMTg (Fig. 10). Rep-
resentative plots of these results for the PPTg/VTA, DR/
VTA, and DR/PPTg injection combinations showing
rostral (Fig. 11a, d, g) and more caudal (Fig. 11b, e, h)
RMTg levels are shown in Fig. 11a–i
Discussion
Neuroanatomical characterization of the RMTg has
revealed that it is a GABAergic structure with dense
afferent inputs from the LHb and SN and outputs to the
VTA/SNC and other brainstem structures, including the
PPTg, DR, and RtGi (Jhou et al. 2009b). The present study
was undertaken to identify if RMTg neurons that project to
the PPTg and DR also express Fos upon acute psycho-
stimulant drug administration, as do RMTg neurons that
project to the VTA/SNC (Geisler et al. 2008; Jhou et al.
2009b). VTA-projecting RMTg neurons that express Fos in
response to psychostimulant administration are concen-
trated within the dense focus of Fos-expressing neurons
Fig. 10 Retrogradely labeled neurons in the RMTg following
injections of CTb in the DR and FG in the PPTg. a FG injection
site in the PPTg (black); CTb injection site in the DR (brown).
b Adjacent section processed for 5-HT immunoreactivity (black)
veriﬁes that the brown injection shown in a is in the DR. c Adjacent
section processed for Nos immunoreactivity (black) veriﬁes that the
black injection shown in a is in the PPTg, pars dissipata. d CTb-
labeled neurons (yellow arrows) and FG-labeled neurons (white
arrows) in the RMTg. e–g Immunoﬂuorescence images of RMTg
neurons showing FG-labeled RMTg neurons (e, magenta), CTb-
labeled RMTg neurons (f, green), and a merged image (g). White
arrows indicate double labeling (e–g). PPTg c pedunculopontine
tegmental nucleus, pars compacta; PPTg d pedunculopontine teg-
mental nucleus, pars dissipata; IPN interpeduncular nucleus. Scale
bars 400 lmi na–c; 100 lmi nd and e
730 Brain Struct Funct (2012) 217:719–734
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such neurons were also present in the region immediately
surrounding the RMTg, diminishing in number with
increasing distance from the RMTg (Geisler et al. 2008).
Presumably, RMTg neurons projecting to the PPTg and DR
and expressing Fos after psychostimulants could be simi-
larly distributed. Accordingly, double labeling in the
RMTg was contrasted in the present study with that in
the immediately surrounding region in order to emphasize
the distinct character of the RMTg (Fig. 7).
Our current results for the VTA projections replicate
those of our earlier study (Geisler et al. 2008) indicating
that 48% of RMTg neurons that project to the VTA, as
shown by retrograde labeling, express Fos following
administration of methamphetamine (10 mg/kg), whereas
only 13% of VTA-projecting neurons expressed Fos in the
region just outside the RMTg. Also consistent with the
previous study, the abundance of retrogradely labeled, Fos-
expressing neurons in the rest of brainstem was negligible
by comparison, although this was not objectively quanti-
tated as was done in the previous study (Geisler et al.
2008). In turn, we found that 56% of RMTg neurons that
project to the PPTg pars dissipata expressed Fos after
methamphetamine, compared with 19% of PPTg-project-
ing neurons just outside the RMTg. Similarly, 47% of
RMTg neurons that project to the DR expressed Fos,
compared with 9% of DR-projecting neurons just outside
the RMTg. The results for injections into the RtGi were
surprising, however, with only 8% of retrogradely labeled
RMTg neurons expressing Fos, compared with 15% of
RtGi-projecting neurons just outside the RMTg. Overall,
these results indicate that neurons in the RMTg that express
Fos following methamphetamine administration project to
the VTA, PPTg pars dissipata, and DR, but not
Fig. 11 Representative plots at rostral (a, d, g) and caudal (b, e, h)
levels of the RMTg (small black circles) from cases that received
injections of CTb tracer in the PPTg and FG in the VTA (a–c), cases
that received injections of CTb tracer in the DR and FG in the VTA
(d–f), and cases that received injections of CTb tracer in the DR and
FG in the PPTg (g–i) and were processed to exhibit retrogradely
labeled neurons. Brains were injected on the sides indicated by the
asterisks. Large blue circles indicate the regions bordering the RMTg.
c, f, and i Show enlargements of the caudal levels. Black triangles
FG-containing neurons, blue dots CTb-containing neurons; red
circles double-labeled neurons
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123substantially to the RtGi. In view of these results, we
speculated that single neurons in the RMTg may project to
more than one of these structures. Indeed, when the VTA
and PPTg were injected in the present study with different
retrograde tracers, 9% of retrogradely labeled neurons in
the RMTg carried both tracers. When the VTA and DR
were injected with different retrograde tracers, 10% of the
retrogradely labeled neurons in the RMTg were double
labeled. When the PPTg and DR were injected with dif-
ferent retrograde tracers, 5% of retrogradely labeled neu-
rons in the RMTg carried both tracers. These results
indicate that a signiﬁcant number of RMTg neurons project
to multiple targets.
RMTg projections to the PPTg and DR have received
little consideration by comparison with those to the VTA/
SNC. The PPTg has cholinergic (Oakman et al. 1995;
Omelchenko and Sesack 2006), glutamatergic (Charara
et al. 1996; Clements and Grant 1990; Geisler et al. 2007),
and GABAergic (Charara et al. 1996; Jia et al. 2003; Hui-
Ling and Morales 2009) projections to the VTA, and the
data reported herein indicate that some or all of these are
likely subject to RMTg modulation. It is well established
that the VTA plays a prominent role in the initiation of
behavioral sensitization (Vanderschuren and Kalivas 2000;
Colussi-Mas et al. 2007) and increasing evidence impli-
cates PPTg involvement as well (Alderson et al. 2003;
Nelson et al. 2007). The present data indicate that the
RMTg is also likely to inﬂuence the initiation of sensiti-
zation insofar as it appears anatomically positioned to
coordinately regulate both the VTA/SNC and PPTg. As
single neurons in the RMTg project to both the VTA and
the PPTg, it seems reasonable to speculate that the RMTg
mayservetocoordinateactivityinthesestructures.However,
an alternative possibility exists that RMTg projections to
the PPTg may exert less inﬂuence on VTA-projecting
PPTg neurons than on PPTg neurons with other functional
consequences, such as, e.g., modulation of spinal motor
neuron excitability (Scarnati et al. 2011).
Neurons of the DR are primarily serotoninergic
(Aghajanian et al. 1967; Baker et al. 1991; Molliver 1987),
and, like the VTA/SNC (Christoph et al. 1986; Jhou et al.
2009a; Matsumoto and Hikosaka 2007) are inhibited by
stimulation of LHb (Stern et al. 1979), as is release of
serotonin by ascending projections from the raphe (Nis-
hikawa and Scatton 1985). Due to the strong neuronal
projections from the RMTg to the DR, it seems likely that
the RMTg acts to modulate the signal from the LHb to the
DR (Herkenham and Nauta 1979). Hikosaka (2010) has
suggested that DR neurons may monitor the stressfulness
of situations in the service of developing appropriate
behavioral responses. The RMTg may convey information
integrated from a variety of different descending pathways
(Jhou et al. 2009b; Kauﬂing et al. 2009), and conduct it to
the DR in order to facilitate the synthesis of appropriate
responses by that structure. As was observed for RMTg
projections to the PPTg, single RMTg neurons project both
to the DR and VTA, suggesting again that single RMTg
neurons may coordinate utilization of multiple neuro-
transmitters in several structures.
Despite convincing evidence from PHA-L injections
that the RtGi is a target of strong RMTg projection (Jhou
et al. 2009b), the present results shed doubt on this con-
clusion. The percentage of retrogradely labeled neurons
that expressed Fos in the RMTg following CTb injections
into the RtGi was no different than in areas surrounding the
RMTg and no focal accumulation of retrogradely labeled
neurons in the RMTg was observed. To the contrary, ret-
rogradely labeled neurons were relatively dense following
these injections in much of the midbrain tegmentum
including the retrorubral ﬁeld, which is known to give rise
to a robust descending projection to the vicinity of the RtGi
(von Krosigk and Smith 1991; von Krosigk et al. 1992).
Presumably in the earlier study (Jhou et al. 2009b), PHA-L
labeled these descending projections or ones akin to them.
The present result leads to the idea that the RMTg may be
more involved in the modulation of structures that give rise
to strong ascending projections, such as the VTA/SNC,
PPTg, and DR, than in structures that have mainly
descending outputs, such as the RtGi.
Recent studies of the RMTg demonstrate that it is
activated and exhibits Fos expression in response to
aversive stimuli or reward omission and inhibited by
rewards and reward-predictive stimuli (Jhou et al. 2009a;
Hong et al. 2011). RMTg neurons also express Fos in
response to acute and repeated exposure to psychostimu-
lants (Colussi-Mas et al. 2007; Geisler et al. 2008; Jhou
et al. 2009a, b; Kauﬂing et al. 2010a, b; Perrotti et al.
2005; Scammell et al. 2000), but this does not necessarily
indicate that psychostimulants activate RMTg neurons
(Zahm et al. 2010). To the contrary, Lecca et al. (2011)
have shown the inhibition of RMTg neurons in response
to psychostimulant administration in which case the Fos
expression can be better explained as accompanying
transcriptional regulation associated with neuronal inhi-
bition. Alternatively, systemically administered psycho-
stimulants may produce an initial depression of RMTg
neuronal activity (associated with disinhibition of the DA
neurons, DA release in the Acb, and euphoria) followed
by a rebound excitation, during which Fos is expressed,
that would depress DA release and be aversive (TC Jhou,
personal communication). This idea is consistent with the
observation that both appetitive and aversive sensations
commonly accompany administration of psychostimulant
drugs of abuse (Hutchison and Riley 2008; Lecca et al.
2011; Simpson and Riley 2005; Wise et al. 1976). Our
evidence for single RMTg neurons projecting to multiple
732 Brain Struct Funct (2012) 217:719–734
123structures involved in the regulation of VTA/SNC neu-
ronal activity and thus DA release supports this idea. This
system of brainstem connections warrants further consid-
eration when one thinks about how appetitively and
aversively affective stimuli enlist opponent processes that
underlie adaptive responses to environmental stimuli and
maladaptive ones following repeated exposure to drugs of
abuse (Daw et al. 2002; Fields 2007; Koob and Le Moal
2008; Hikosaka 2010; Jhou et al. 2009a, b; Matsumoto
and Hikosaka 2007).
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